Page: Viewing Company

Home Icon Home SEC Icon SEC
Create Alert

Viewing Company

Edit Company
Company Name: NIKA PHARMACEUTICALS, INC.
CIK: 1145604
Phone: None
Fiscal Year End: None
Entity Type:
SIC: -
Category Type:
Entity Name: None
First Filing Date: 2021-03-24
Last Filing Date: 2025-05-13
SEC Filings
Start End Frame Filed ACCN Value View
2022-01-01 2023-03-31 CY2023Q1I 2023-05-15 0001826466-23-000022 $ 41,345 View
2022-01-01 2023-06-30 CY2023Q2I 2023-08-21 0001826466-23-000031 $ 3,382,790 View
2020-01-01 2020-12-31 CY2019 2021-03-24 0001826466-21-000075 $ 13,203,000 View
2021-01-01 2021-03-31 CY2021Q1 2021-05-13 0001826466-21-000097 $ 13,203,000 View
2021-04-01 2021-06-30 CY2021Q2 2021-08-11 0001826466-21-000118 $ 13,203,000 View
2021-07-01 2021-09-30 CY2021Q3 2021-11-12 0001826466-21-000137 $ 13,203,000 View
2021-01-01 2021-12-31 CY2021 2022-03-03 0001826466-22-000017 $ 0 View
2022-01-01 2023-09-30 CY2023Q3I 2023-10-31 0001826466-23-000038 $ 3,392,933 View
2023-01-01 2023-12-31 CY2023Q4I 2024-04-01 0001826466-24-000041 $ 3,400,247 View
2024-01-01 2024-03-31 CY2024Q1I 2024-05-28 0001826466-24-000068 $ 17,007 View
2022-04-01 2022-06-30 CY2022Q2I 2022-08-22 0001826466-22-000111 $ 10,000 View
2022-01-01 2022-06-30 CY2021Q2I 2022-11-07 0001826466-22-000138 $ 10,000 View
2022-01-01 2022-07-20 CY2022Q2I 2022-11-10 0001826466-22-000142 $ 846,887,000 View
2024-01-01 2024-06-30 CY2024Q2I 2024-09-18 0001826466-24-000120 $ 5,000,000 View
2024-01-01 2024-06-30 CY2024Q2I 2024-11-01 0001826466-24-000136 $ 5,000,000 View
2024-01-01 2024-09-30 CY2024Q3I 2024-11-12 0001826466-24-000146 $ 5,000,000 View
2024-01-01 2024-12-31 CY2024Q4I 2025-03-31 0001826466-25-000030 $ 15,851 View
2025-01-01 2025-03-31 CY2025Q1I 2025-05-13 0001826466-25-000058 $ 15,851 View
2022-01-01 2022-03-31 CY2021Q1 2022-05-12 0001826466-22-000057 $ 13,203,000 View
2022-01-01 2022-12-31 CY2022Q4I 2023-04-10 0001826466-23-000014 $ 0 View
SEC Facts By Type
Type Name Description View
us-gaap Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. View
us-gaap Federal Income Tax Expense (Benefit), Continuing Operations Amount of current and deferred federal income tax expense (benefit) attributable to income (loss) from continuing operations. View
us-gaap General and Administrative Expense The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. View
us-gaap Cash and Cash Equivalents, Period Increase (Decrease) Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. View
us-gaap Cash Equivalents, at Carrying Value Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Business Development Business development involves the development of products and services, their delivery, design and their implementation. Business development includes a number of techniques designed to grow an economic enterprise. Such techniques include, but are not limited to, assessments of marketing opportunities and target markets, intelligence gathering on customers and competitors, generating leads for possible sales, follow-up sales activity, formal proposal writing and business model design. Business development involves evaluating a business and then realizing its full potential, using such tools as marketing, sales, information management and customer service. View
us-gaap Increase (Decrease) in Accounts Payable The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Increase (Decrease) in Accounts Payable and Accrued Liabilities The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. View
us-gaap Increase (Decrease) in Accounts Receivable The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. View
us-gaap Noncash or Part Noncash Acquisition, Value of Assets Acquired "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Other Receivables, Net, Current Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. View
us-gaap Professional Fees A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. View
us-gaap Property, Plant and Equipment, Net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. View
us-gaap Property, Plant and Equipment, Other, Gross Amount before accumulated depreciation, depletion and amortization of other physical assets used in the normal conduct of business to produce goods and services and not intended for resale. View
us-gaap Property, Plant and Equipment, Other, Net Amount after depreciation of long-lived, physical assets used to produce goods and services and not intended for resale, classified as other. View
us-gaap Real Estate Investment Partnership Revenue Amount of revenue recognized from investments in real estate partnerships and variable interest entities. View
us-gaap Retained Earnings, Unappropriated A segregation of retained earnings which is available for dividend distribution. Earnings not paid out as dividends but instead reinvested in the core business or used to pay off debt. Unappropriated profit is part of shareholder equity. Also called cumulative distributions or earned surplus or accumulated earnings or unappropriated profit. View
us-gaap Stock Issued During Period, Shares, Other Number of shares of stock issued attributable to transactions classified as other. View
us-gaap Prepaid Expense, Current Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. View
us-gaap 4296601 None View
us-gaap Prepaid Expense and Other Assets Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets. View
us-gaap Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Percentage of domestic federal statutory tax rate applicable to pretax income (loss). View
dei Entity Common Stock, Shares Outstanding Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. View
dei Entity Public Float The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. View
dei Entity Listing, Par Value Per Share The par value per share of security quoted in same currency as Trading currency. Example: '0.01'. View
us-gaap Earnings Per Share, Basic and Diluted The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Additional Paid in Capital Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. View
us-gaap Assets Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Assets, Current Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. View
us-gaap Cash Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash and Cash Equivalents, at Carrying Value Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. View
us-gaap Common Stock, Par or Stated Value Per Share Face amount or stated value per share of common stock. View
us-gaap Common Stock, Shares Authorized The maximum number of common shares permitted to be issued by an entity's charter and bylaws. View
us-gaap Common Stock, Shares, Issued Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. View
us-gaap Common Stock, Shares, Outstanding Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. View
us-gaap Common Stock, Value, Issued Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. View
us-gaap Deferred Tax Assets, Operating Loss Carryforwards, State and Local Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. View
us-gaap Deferred Tax Assets, Valuation Allowance Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Due to Related Parties, Noncurrent Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer. View
us-gaap Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. View
us-gaap Increase (Decrease) in Prepaid Expense The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods. View
us-gaap Liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. View
us-gaap Liabilities and Equity Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. View
us-gaap Net Cash Provided by (Used in) Financing Activities Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. View
us-gaap Net Cash Provided by (Used in) Operating Activities Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. View
us-gaap Net Income (Loss) Attributable to Parent The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. View
us-gaap Operating Expenses Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. View
us-gaap Operating Income (Loss) The net result for the period of deducting operating expenses from operating revenues. View
us-gaap Preferred Stock, Par or Stated Value Per Share Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Preferred Stock, Shares Authorized The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. View
us-gaap Preferred Stock, Shares Issued Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. View
us-gaap Preferred Stock, Value, Outstanding Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders. View
us-gaap Proceeds from Related Party Debt The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. View
us-gaap Net Income (Loss), Including Portion Attributable to Noncontrolling Interest The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. View
us-gaap Retained Earnings (Accumulated Deficit) The cumulative amount of the reporting entity's undistributed earnings or deficit. View
us-gaap Stockholders' Equity Attributable to Parent Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. View
us-gaap Stock Issued During Period, Shares, Acquisitions Number of shares of stock issued during the period pursuant to acquisitions. View
us-gaap Weighted Average Number of Shares Outstanding, Basic and Diluted Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). View
us-gaap Deferred Income Tax Expense (Benefit) Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Due to Related Parties, Current Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Increase (Decrease) in Operating Capital The increase (decrease) during the reporting period of all assets and liabilities used in operating activities. View
us-gaap Liabilities, Current Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. View
us-gaap Operating Loss Carryforwards Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. View
us-gaap Preferred Stock, Shares Outstanding Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. View
us-gaap Revenues Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). View
us-gaap Adjustments to Additional Paid in Capital, Other Amount of other increase (decrease) in additional paid in capital (APIC). View
us-gaap Earnings Per Share, Basic The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. View
us-gaap Earnings Per Share, Diluted The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. View
us-gaap Notes Payable, Related Parties, Current The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Notes Reduction The value of notes retired (or transferred to another entity) in noncash investing or financing transactions. View
us-gaap Weighted Average Number of Shares Outstanding, Diluted The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. View
us-gaap Weighted Average Number of Shares Outstanding, Basic Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. View
us-gaap Accounts Payable, Current Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). View
us-gaap Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock. View
us-gaap Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs Amount of increase in additional paid in capital (APIC) resulting from issuance costs from a share-lending arrangement entered into, in contemplation of a convertible debt offering or other financing. View
us-gaap Business Combination, Acquisition Related Costs This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. View
us-gaap Common Stock, No Par Value Face amount per share of no-par value common stock. View
us-gaap Common Stock, Value, Outstanding Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares. View
us-gaap Payments for Repurchase of Common Stock The cash outflow to reacquire common stock during the period. View
us-gaap Preferred Stock, Value, Issued Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. View
us-gaap Sale of Stock, Number of Shares Issued in Transaction The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. View
us-gaap Sale of Stock, Price Per Share Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. View
us-gaap Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Value of preferred stock and warrants for common stock issued. View
us-gaap Stock Issued During Period, Shares, Issued for Services Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Shares, New Issues Number of new stock issued during the period. View
us-gaap Stock Issued During Period, Value, Issued for Services Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. View
us-gaap Stock Issued During Period, Value, New Issues Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. View
us-gaap Debt Conversion, Converted Instrument, Amount "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." View
us-gaap Proceeds from Issuance of Common Stock The cash inflow from the additional capital contribution to the entity. View
us-gaap Business Acquisition, Percentage of Voting Interests Acquired Percentage of voting equity interests acquired at the acquisition date in the business combination. View
us-gaap Preferred Stock, No Par Value Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer. View
us-gaap Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) Other than shares newly issued, the number of additional shares issued (for example, a stock split) or canceled (for example, to correct a share issuance), during the period under the plan. View
us-gaap Common Stock Dividends, Shares Number of shares of common stock issued as dividends during the period. Excludes stock splits. View
us-gaap Current Federal Tax Expense (Benefit) Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations. View
us-gaap Effective Income Tax Rate Reconciliation, Tax Contingency, State and Local, Percent Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax contingency. View
us-gaap Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. View
us-gaap Tax Credit Carryforward, Valuation Allowance Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized. View
us-gaap Debt, Current Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer. View
us-gaap Cumulative Earnings (Deficit) Amount of cumulative earnings (deficits) for relevant time periods. View
us-gaap Accounts Payable and Accrued Liabilities, Current Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. View
us-gaap Increase (Decrease) in Inventories The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. View
us-gaap Inventory, Net Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. View
us-gaap Noncash Merger Related Costs Amount of expense (income) related to the increase (decrease) in reserve for business combination costs. Includes, but is not limited to, legal, accounting, and other costs incurred to consummate the merger. View
us-gaap Short-term Debt Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer. View
us-gaap Weighted Average Cost Inventory Amount The amount of weighted average cost inventory present at the reporting date when inventory is valued using different valuation methods. View
us-gaap Accounts Receivable, after Allowance for Credit Loss, Current Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. View
us-gaap Buildings and Improvements, Gross Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing. View
us-gaap Business Acquisition, Transaction Costs Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. View
us-gaap Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. View
us-gaap Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. View
us-gaap Contribution of Property Value of property contributed in noncash investing and financing activities. View
us-gaap Increase (Decrease) in Accounts and Other Receivables The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables. View
us-gaap Land Amount before accumulated depletion of real estate held for productive use, excluding land held for sale. View
Chart of Accounts => Accounts
Name View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations View
Net Cash Provided by (Used in) Operating Activities View
Accounts Receivable, after Allowance for Credit Loss, Current View
Increase (Decrease) in Accounts Receivable View
Land View
Noncash or Part Noncash Acquisition, Value of Assets Acquired View
Other Receivables, Net, Current View
Professional Fees View
Property, Plant and Equipment, Net View
Property, Plant and Equipment, Other, Gross View
Property, Plant and Equipment, Other, Net View
Real Estate Investment Partnership Revenue View
Retained Earnings, Unappropriated View
Stock Issued During Period, Shares, Other View
Prepaid Expense, Current View
4258927 View
Prepaid Expense and Other Assets View
Accumulated Other Comprehensive Income (Loss), Net of Tax View
Additional Paid in Capital View
Assets View
Assets, Current View
Cash View
Cash and Cash Equivalents, at Carrying Value View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect View
Common Stock, Par or Stated Value Per Share View
Common Stock, Shares Authorized View
Common Stock, Shares, Issued View
Common Stock, Shares, Outstanding View
Common Stock, Value, Issued View
Deferred Tax Assets, Operating Loss Carryforwards View
Deferred Tax Assets, Operating Loss Carryforwards, State and Local View
Deferred Tax Assets, Valuation Allowance View
Due to Related Parties, Noncurrent View
Earnings Per Share, Basic and Diluted View
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent View
Federal Income Tax Expense (Benefit), Continuing Operations View
General and Administrative Expense View
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest View
Increase (Decrease) in Prepaid Expense View
Liabilities View
Liabilities and Equity View
Net Cash Provided by (Used in) Financing Activities View
Net Income (Loss) Attributable to Parent View
Operating Expenses View
Operating Income (Loss) View
Preferred Stock, Par or Stated Value Per Share View
Preferred Stock, Shares Authorized View
Preferred Stock, Shares Issued View
Preferred Stock, Value, Outstanding View
Proceeds from Related Party Debt View
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest View
Retained Earnings (Accumulated Deficit) View
Stockholders' Equity Attributable to Parent View
Stock Issued During Period, Shares, Acquisitions View
Weighted Average Number of Shares Outstanding, Basic and Diluted View
Cash and Cash Equivalents, Period Increase (Decrease) View
Cash Equivalents, at Carrying Value View
Deferred Income Tax Expense (Benefit) View
Due to Related Parties, Current View
Increase (Decrease) in Operating Capital View
Liabilities, Current View
Operating Loss Carryforwards View
Preferred Stock, Shares Outstanding View
Revenues View
Adjustments to Additional Paid in Capital, Other View
Earnings Per Share, Basic View
Earnings Per Share, Diluted View
Notes Payable, Related Parties, Current View
Notes Reduction View
Weighted Average Number of Shares Outstanding, Diluted View
Weighted Average Number of Shares Outstanding, Basic View
Accounts Payable, Current View
Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock View
Adjustments to Additional Paid in Capital, Stock Issued, Own-share Lending Arrangement, Issuance Costs View
Business Combination, Acquisition Related Costs View
Business Development View
Common Stock, No Par Value View
Common Stock, Value, Outstanding View
Increase (Decrease) in Accounts Payable View
Payments for Repurchase of Common Stock View
Preferred Stock, Value, Issued View
Sale of Stock, Number of Shares Issued in Transaction View
Sale of Stock, Price Per Share View
Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants View
Stock Issued During Period, Shares, Issued for Services View
Stock Issued During Period, Shares, New Issues View
Stock Issued During Period, Value, Issued for Services View
Stock Issued During Period, Value, New Issues View
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents View
Debt Conversion, Converted Instrument, Amount View
Proceeds from Issuance of Common Stock View
Business Acquisition, Percentage of Voting Interests Acquired View
Preferred Stock, No Par Value View
Share-based Compensation Arrangement by Share-based Payment Award, Other Share Increase (Decrease) View
Common Stock Dividends, Shares View
Current Federal Tax Expense (Benefit) View
Effective Income Tax Rate Reconciliation, Tax Contingency, State and Local, Percent View
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount View
Tax Credit Carryforward, Valuation Allowance View
Debt, Current View
Cumulative Earnings (Deficit) View
Accounts Payable and Accrued Liabilities, Current View
Increase (Decrease) in Accounts Payable and Accrued Liabilities View
Increase (Decrease) in Inventories View
Inventory, Net View
Noncash Merger Related Costs View
Short-term Debt View
Weighted Average Cost Inventory Amount View
Buildings and Improvements, Gross View
Business Acquisition, Transaction Costs View
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable View
Comprehensive Income (Loss), Net of Tax, Attributable to Parent View
Contribution of Property View
Increase (Decrease) in Accounts and Other Receivables View